{"entity":{"type":"insider","cik":"0001663609","url":"/insider/0001663609","json_url":"/insider/0001663609.json","name":"Dissanayake Shehan Bharatha","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2017-01-10","last":"2023-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Dissanayake Shehan Bharatha","source":"filing","n_filings":5,"first_seen":"2017-01-10","last_seen":"2023-08-15"}],"transactions":[{"id":8644021,"accession":"0000895345-23-000499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000499","line_url":"/filing/0000895345-23-000499","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1258973.0,"shares_display":"1,258,973","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":34999449.4,"total_display":"34,999,449.40","total_whole":"34,999,449","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":8421038,"accession":"0000895345-23-000500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000500","line_url":"/filing/0000895345-23-000500","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1258973.0,"shares_display":"1,258,973","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":34999449.4,"total_display":"34,999,449.40","total_whole":"34,999,449","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":4350749,"accession":"0000899243-21-010812","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400005.0,"shares_display":"400,005","price_per_share":181.14999812502344,"price_display":"181.15","price_state":"stated","total_value":72460905.0,"total_display":"72,460,905.00","total_whole":"72,460,905","shares_owned_after":2000000.0,"shares_owned_after_display":"2,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider","n_lines":4},{"id":2908017,"accession":"0000899243-20-030060","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030060","line_url":"/filing/0000899243-20-030060","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Davis Aaron I.; Boxer Capital, LLC; MVA Investors, LLC; Fuglesang Christopher","owner_display_name":"LEWIS JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":202.0,"price_display":"202.00","price_state":"stated","total_value":80800000.0,"total_display":"80,800,000.00","total_whole":"80,800,000","shares_owned_after":1404610.0,"shares_owned_after_display":"1,404,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-10-30","scope":"insider","n_lines":2},{"id":4645621,"accession":"0000899243-17-000987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-000987","line_url":"/filing/0000899243-17-000987","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LAPPE RODNEY W; LEWIS JOSEPH; Boxer Capital, LLC; Davis Aaron I.; Reisman Neil; MVA Investors, LLC; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Fuglesang Christopher","owner_display_name":"LAPPE RODNEY W","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":286163.0,"shares_display":"286,163","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":1602512.8,"total_display":"1,602,512.80","total_whole":"1,602,513","shares_owned_after":1037994.0,"shares_owned_after_display":"1,037,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-06","filed_date":"2017-01-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2017-01-10","last_seen":"2023-08-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001663609","retrieved_at":"2026-08-27T14:02:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}